| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |